标题
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
作者
关键词
-
出版物
Cancer Discovery
Volume 13, Issue 6, Pages 1364-1385
出版商
American Association for Cancer Research (AACR)
发表日期
2023-03-29
DOI
10.1158/2159-8290.cd-22-1427
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Genetic Evolution of Metastasis
- (2022) Aljosja Rogiers et al. CANCER RESEARCH
- Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis
- (2022) Kevin Kleffman et al. Cancer Discovery
- Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
- (2022) Jana Biermann et al. CELL
- Macrophage diversity in cancer revisited in the era of single-cell omics
- (2022) Ruo-Yu Ma et al. TRENDS IN IMMUNOLOGY
- MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis
- (2022) Francisco M. Barriga et al. Nature Cancer
- The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
- (2021) Alvin P. Makohon-Moore et al. CLINICAL CANCER RESEARCH
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- (2021) Kevin Litchfield et al. CELL
- Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling
- (2021) Ismael A. Vergara et al. Nature Communications
- Cancer evolution: Darwin and beyond
- (2021) Roberto Vendramin et al. EMBO JOURNAL
- 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
- (2021) Guangchun Han et al. Nature Communications
- PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC
- (2021) Lisa-Marie Appel et al. Nature Communications
- New survival standards for advanced melanoma
- (2020) Lavinia Spain et al. BRITISH JOURNAL OF CANCER
- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- The nf-core framework for community-curated bioinformatics pipelines
- (2020) Philip A. Ewels et al. NATURE BIOTECHNOLOGY
- Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
- (2020) Saioa López et al. NATURE GENETICS
- Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
- (2020) Eva Pérez-Guijarro et al. NATURE MEDICINE
- Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
- (2020) Kevin Litchfield et al. Cell Reports
- The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
- (2020) Rita Cabrita et al. Cancers
- Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition
- (2020) Bryan Ngo et al. Cancer Discovery
- Pervasive chromosomal instability and karyotype order in tumour evolution
- (2020) Thomas B. K. Watkins et al. NATURE
- Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
- (2020) Jonas Ecker et al. NEURO-ONCOLOGY
- Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
- (2020) Roy Rabbie et al. Nature Communications
- Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
- (2019) Grant M. Fischer et al. Cancer Discovery
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
- (2019) Stephen A. Luebker et al. Frontiers in Oncology
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site‐specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti–PD‐1 therapy
- (2019) Ines Pires da Silva et al. CANCER
- Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods
- (2019) Alejandro Jiménez-Sánchez et al. CANCER RESEARCH
- Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis
- (2019) Yongkang Zou et al. Cancer Discovery
- T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
- (2019) Christina M. Paluskievicz et al. Frontiers in Immunology
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- (2019) Inna Smalley et al. EBioMedicine
- The MYC oncogene is a global regulator of the immune response
- (2018) Stephanie C. Casey et al. BLOOD
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
- (2018) Ana C. deCarvalho et al. NATURE GENETICS
- Genome doubling shapes the evolution and prognosis of advanced cancers
- (2018) Craig M. Bielski et al. NATURE GENETICS
- Patterns of genomic evolution in advanced melanoma
- (2018) E. Birkeland et al. Nature Communications
- Does relaxing the infinite sites assumption give better tumor phylogenies? An ILP-based comparative approach
- (2018) Paola Bonizzoni et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- 218 Divergent Clonal Evolution of Melanoma Brain Metastases in Response to Immunotherapy
- (2018) Christopher Alvarez-Breckenridge et al. NEUROSURGERY
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Genomic landscape of DNA repair genes in cancer
- (2016) Young Kwang Chae et al. Oncotarget
- Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
- (2016) Marieke I.G. Raaijmakers et al. Oncotarget
- Multiomic Analysis of the UV-Induced DNA Damage Response
- (2016) Stefan Boeing et al. Cell Reports
- Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
- (2016) R. F. Sweis et al. Cancer Immunology Research
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
- (2015) Douglas B. Johnson et al. EUROPEAN JOURNAL OF CANCER
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
- (2015) Michael Krauthammer et al. NATURE GENETICS
- Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
- (2015) J. Zachary Sanborn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Architectures and Driver Mutations in Metastatic Melanomas
- (2014) Li Ding et al. PLoS One
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma
- (2013) Ken Dutton-Regester et al. Pigment Cell & Melanoma Research
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
- (2011) Mitchell S Stark et al. NATURE GENETICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search